Tonix Pharmaceuticals Holding Corp. (TNXP)

Latest News

View all news

Apr 24, 2025

Tonix Pharmaceuticals Presented Data on Potential Mpox Vaccine TNX-801 at World Vaccine Congress Washington 2025

Apr 16, 2025

Tonix Pharmaceuticals Announces Oral Presentation and Panel Participation at the World Vaccine Congress Washington 2025

Apr 9, 2025

Tonix Pharmaceuticals and Makana Therapeutics Announce Collaboration Combining Tonix’s Anti-CD40L Monoclonal Antibody (TNX-1500) with Makana’s Genetically Engineered Organs in Preclinical and Clinical Xenotransplantation Studies

View all news

World Vaccine Congress 2025

View Presentation

Annual Meeting of Shareholders

View Event Add to Calendar View All Events

Latest Financial Results

FY 2024

Fiscal Year Ended Dec 31, 2024

Earnings Release

10-K

PDF HTML

XBRL

ZIP XLS HTML

Latest Annual Filing

For Fiscal Year Ending Dec 31, 2024

IR Contacts

Company

Tonix Pharmaceuticals Holding Corp.
26 Main Street
Suite 101
Chatham, NJ 07928
T: 862-799-8599
investor.relations@tonixpharma.com

Investor Relations

TONIX Pharmaceuticals
investor.relations@tonixpharma.com

Transfer Agent

VStock Transfer, LLC
77 Spruce Street
Suite 201
Cedarhurst, NY 11516
T: 212-828-8436
https://www.vstocktransfer.com

Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.